Dipeptidyl peptidase 3, a biomarker in cardiogenic shock and hopefully much more

Eur J Heart Fail. 2020 Feb;22(2):300-302. doi: 10.1002/ejhf.1649. Epub 2019 Dec 15.

Authors

Aurora Magliocca¹, Torbjørn Omland^{2

3}, Roberto Latini¹

Affiliations

¹ Department of Cardiovascular Medicine, Istituto di Ricerche Farmacologiche Mario Negri - IRCCS, Milano, Italy.
² Department of Cardiology, Akershus University Hospital, Oslo, Norway.
³ Center for Heart Failure Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

PMID: 31840335
DOI: 10.1002/ejhf.1649

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Arrhythmia Agents*
Biomarkers
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Heart Failure* / diagnosis
Hemodynamics
Humans
Shock, Cardiogenic / diagnosis

Substances

Anti-Arrhythmia Agents
Biomarkers
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases